Abemaciclib with endocrine therapy for adjuvant treatment of hormone receptor-positive, HER2-negative, node-positive early breast cancer at high risk of recurrence
Technology appraisal guidance
Reference number: TA810
Published:
Tools and resources
Tools and resources to help you put the guidance into practice.